0L8Z Stock Overview
ContextVision AB (publ), a medical technology software company, provides image analysis and imaging for medical systems in Asia, Europe, and America.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
ContextVision AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr6.10 |
| 52 Week High | kr9.35 |
| 52 Week Low | kr6.10 |
| Beta | 1.09 |
| 1 Month Change | -10.03% |
| 3 Month Change | -27.16% |
| 1 Year Change | -35.67% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -4.32% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0L8Z | GB Healthcare Services | GB Market | |
|---|---|---|---|
| 7D | -1.6% | -2.9% | 1.7% |
| 1Y | -35.7% | 36.7% | 1.4% |
Return vs Industry: 0L8Z underperformed the UK Healthcare Services industry which returned 35.9% over the past year.
Return vs Market: 0L8Z underperformed the UK Market which returned 1.1% over the past year.
Price Volatility
| 0L8Z volatility | |
|---|---|
| 0L8Z Average Weekly Movement | 8.3% |
| Healthcare Services Industry Average Movement | 8.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0L8Z's share price has been volatile over the past 3 months.
Volatility Over Time: 0L8Z's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 40 | Gerald Potzsch | www.contextvision.com |
ContextVision AB (publ), a medical technology software company, provides image analysis and imaging for medical systems in Asia, Europe, and America. The company offers image enhancement software for 2D/3D/4D ultrasound, radiography, magnetic resonance imaging (MRI), and veterinary uses. Its products include Rivent that offers image enhancement and visualization solutions for ultrasound systems for women’s health, general imaging, cardiovascular, and point of care applications; Rivent Mobile, a 2D image enhancement product for handheld units; and Rivent 3D, an image enhancement solution for 3D ultrasound.
ContextVision AB (publ) Fundamentals Summary
| 0L8Z fundamental statistics | |
|---|---|
| Market cap | kr461.11m |
| Earnings (TTM) | kr32.97m |
| Revenue (TTM) | kr133.57m |
14.0x
P/E Ratio3.5x
P/S RatioIs 0L8Z overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0L8Z income statement (TTM) | |
|---|---|
| Revenue | kr132.60m |
| Cost of Revenue | kr52.20m |
| Gross Profit | kr80.40m |
| Other Expenses | kr47.67m |
| Earnings | kr32.73m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 08, 2024
| Earnings per share (EPS) | 0.42 |
| Gross Margin | 60.63% |
| Net Profit Margin | 24.68% |
| Debt/Equity Ratio | 0% |
How did 0L8Z perform over the long term?
See historical performance and comparison